Toru Wakamatsu

13PUBLICATIONS
23CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursGene and molecular therapySolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 27, 2026
Establishment of a patient-derived malignant peripheral nerve sheath tumor organoid model reveals SHH pathway activation and therapeutic vulnerability.

|Aug 20, 2026
Establishment of a ZFP64::NCOA3 fusion-positive spindle cell/sclerosing rhabdomyosarcoma organoid model and evaluation of fusion-gene dependency.

|Oct 09, 2025
Establishment of human histiocytic sarcoma organoids dependent on the SHH/YAP pathway.

Yusuke Yoshimura, Keiichi Yoshida, Yukiko Matsuoka

|Jan 24, 2025
Impact of Bone-Modifying Agents on Post-Bone Metastasis Survival Across Cancer Types.

Hironari Tamiya, Kazumi Nishino, Yuji Kato

|Sep 24, 2024
Real-world assessment of comprehensive genome profiling impact on clinical outcomes: A single-institution study in Japan.

Kei Kunimasa, Naotoshi Sugimoto, Tomoyuki Yamasaki

|Jul 01, 2024
Improvement of histone deacetylase inhibitor efficacy by SN38 through TWIST1 suppression in synovial sarcoma.

Satoru Sasagawa, Jun Kumai, Toru Wakamatsu

Pageof 3

Frequent Collaborators

4 joint publications

Hidetatsu Outani

4 joint publications

Satoshi Takenaka

1 joint publications

Akira Myoui

1 joint publications

Hiroshi Kobayashi